ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript September 16, 2024 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported ...
Maintained Buy Rating for ImmunoPrecise Antibodies on Strong Revenue and Strategic Growth Prospects
ImmunoPrecise Antibodies (IPA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Seeking Alpha4d
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript
Good morning, ladies and gentlemen, and thank you for joining us today for ImmunoPrecise Antibodies First Quarter Fiscal Year 2025 Earnings Call. We appreciate your time and interest in our company.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -22.22% and 22.44%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock ...
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic ...
TipRanks on MSN4d
Options Volatility and Implied Earnings Moves Today, September 16, 2024
Today, several major companies are expected to report earnings: Ocean Power Technologies (OPTT), High Tide (HITI) and ...
ImmunoPrecise Antibodies earnings preview: what Wall Street is expecting
ImmunoPrecise Antibodies will report earnings from Q1.Analysts on Wall Street expect ImmunoPrecise Antibodies will release ...